Refenesen Mucus Relief
- Product NDC
- 10956-845
- 11-digit product format
- 109560845
- Labeler code
- 10956
- Product ID
- 10956-845_425102a9-bdd6-4b48-8758-503659b1b7b9
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- Guaifenesin
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Reese Pharmaceutical Co
- Application
- M012
- Marketing category
- OTC MONOGRAPH DRUG
- Marketing start
- 2021-04-15
- Substance
- GUAIFENESIN
- Active strength
- 400 mg/1
- Pharmacologic classes
- Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Refenesen Mucus Relief
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| GUAIFENESIN | 400 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 495W7451VQ |
| Rxcui | 359601 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 10956-845-30 | Refenesen Mucus Relief | 1 in 1 CARTON | TABLET | 1 | | 4 |
| 10956-845-30 | Refenesen Mucus Relief | 30 in 1 BOTTLE, PLASTIC | TABLET | 30 | | 4 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 10956-845 | REFENESEN MUCUS RELIEF (GUAIFENESIN) TABLET [REESE PHARMACEUTICAL CO] | 4 | Current NDC, Legacy NDC, 2 package rows | 20241220_861dffb7-8bf4-4f03-bcc2-ed8a35bc341d.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 10956-845-30 | 10956084530 | 1 BOTTLE, PLASTIC in 1 CARTON (10956-845-30) / 30 TABLET in 1 BOTTLE, PLASTIC | 2021-04-15 | 0000-00-00 | No | No | Current |